Transradial Access Outperforms Transfemoral Intervention in Real-World PCI Patients
Results from the DRAGON study conclude that transradial intervention reduced the incidence of bleeding complications when compared with transfemoral intervention.
TCT Meeting Highlights
Long-Term Prognosis Is Poor for Patients With Severe Aortic Stenosis Managed Conservatively
Conservative management of severe aortic stenosis led to higher all-cause death and heart failure hospitalization rates compared with initial aortic valve replacement.
Valve-in-Valve Registry Data Demonstrate Positive 1-Year Results for Transcatheter Aortic Valve Replacement
Transcatheter aortic valve replacement (TAVR) resulted in low rates of all-cause mortality in high-risk patients with failed surgical bioprostheses.
Next-Generation Transcatheter Valve Associated with High 1-Year Survival Rate in Patients With Aortic Stenosis
TAVR with the Sapien 3 valve demonstrates high 1-year survival rate for high-risk and inoperable patients with aortic stenosis.
RESPECT Trial: Patent Foramen Ovale Closure Reduces Recurrent Cryptogenic Stroke Over Long Term
A patent foramen ovale (PFO) closure device significantly decreases recurrent cryptogenic ischemic stroke in patients with PFO who experienced a cryptogenic stroke.
Bivalirudin Failed to Reduce Major Bleeding, Clinical Events in TAVR vs Heparin
Results from the BRAVO 3 study indicate major bleeding and 30-day net adverse clinical event rate were similar in patients receiving either bivalirudin or heparin during TAVR.
Polymer-Free Drug-Coated Stent Superior to Bare-Metal Stent in Patients With High Bleeding Risk
Polymer-free drug-coated stent demonstrated superiority vs bare-metal stent when used in conjunction with DAPT.
Scoring Balloon Combined With Drug-Coated Balloon May Produce Better Outcomes for Patients With Restenosis
Results from the ISAR-DESIRE 4 clinical trial indicate that use of scoring balloon plus a paclitaxel-coated balloon was angiographically superior compared with drug-coated balloon alone.
Drug-Coated Balloons Demonstrate Favorable Outcomes for Patients With PAD
IN.PACT SFA trial results reveal that drug-coated balloons demonstrate significantly higher primary patency compared with percutaneous transluminal angioplasty for patients with peripheral artery disease.
BIOSOLVE-II Trial: Novel Absorbable Scaffold Performs Well in De Novo Coronary Lesions at 6 Months
Second-generation sirolimus-eluting absorbable metal scaffold demonstrates favorable outcomes in de novo coronary artery lesions, as reported by the BIOSOLVE-II trial.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in TCT Meeting Highlights
Loading... 
Loading...